Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


3M CO   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2021202020192018201720162015201420132012
Period End Date12/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/2012
Net Sales35,355.0032,184.0032,136.0032,765.0031,657.0030,109.0030,274.0031,821.0030,871.0029,904.00
Total Revenues35,355.0032,184.0032,136.0032,765.0031,657.0030,109.0030,274.0031,821.0030,871.0029,904.00
Cost of sales18,795.0016,605.0017,136.0016,682.0016,055.0015,118.0015,383.0016,447.0016,106.0015,685.00
Gross Profit16,560.0015,579.0015,000.0016,083.0015,602.0014,991.0014,891.0015,374.0014,765.0014,219.00
Research, development and related expenses1,994.001,878.001,911.001,821.001,870.001,764.001,763.001,770.001,715.001,634.00
Selling, general and administrative expenses7,197.006,929.007,029.007,602.006,626.006,311.006,229.006,469.006,384.006,102.00
Other (expense) income--------------------
Gain on sale of pharmaceuticals business--389.00114.00547.00586.00111.0047.00------
Total Operating Expenses27,986.0025,023.0025,962.0025,558.0023,965.0023,082.0023,328.0024,686.0024,205.0023,421.00
Operating Income (Loss)7,369.007,161.006,174.007,207.007,692.007,027.006,946.007,135.006,666.006,483.00
Interest expense--------------142.00145.00171.00
Interest income--------------33.0041.0039.00
Other expense (income), net(165.00)(366.00)(531.00)(207.00)(144.00)(26.00)(123.00)------
Pre-Tax Income: United States3,716.003,795.002,954.003,487.004,149.004,366.00--3,815.003,194.002,902.00
Pre-Tax Income - International3,488.003,000.002,689.003,513.003,399.002,687.00--3,211.003,368.003,449.00
Income before income taxes, minority interest and cumulative effect of accounting7,204.006,795.005,643.007,000.007,548.007,053.006,823.007,026.006,562.006,351.00
Current : Federal756.00720.00534.00698.001,022.001,192.00--1,103.00948.00743.00
Current : State104.00123.0059.00109.0059.0075.00--108.0091.0075.00
Provision for income taxes1,285.001,337.001,114.001,637.002,679.001,995.001,982.002,028.001,841.001,840.00
Deferred: Federal(219.00)(44.00)(43.00)(38.00)162.00----(171.00)(123.00)(3.00)
Deferred: State(25.00)(17.00)(28.00)(17.00)15.00----(9.00)(2.00)10.00
Currently payable: International597.00632.00673.00763.00722.00733.00--1,008.00901.00918.00
Deferred: International72.00(77.00)(81.00)(54.00)76.00----(11.00)26.0097.00
Minority interest--------------------
Income (loss) from unconsolidated subsidiaries, net of taxes10.00(5.00)----------------
INCOME BEFORE CUMULATIVE EFFECT OF ACCOUNTING CHANGE--------------------
Cumulative effect of accounting change--------------------
Net income including noncontrolling interest5,929.005,453.004,529.005,363.004,869.005,058.004,841.004,998.004,721.004,511.00
Less- Net income attributable to noncontrolling interest8.004.0012.0014.0011.008.008.0042.0062.0067.00
Net Income (Loss) Available to Common Shareholders5,921.005,449.004,517.005,349.004,858.005,050.004,833.004,956.004,659.004,444.00
Basic: Income before cumulative effect of accounting change--------------------
Basic: Cumulative effect of accounting change--------------------
Earnings per share - Basic10.239.437.839.098.138.357.727.636.836.40
Diluted: Income before cumulative effect of accounting change--------------------
Diluted: Cumulative effect of accounting change--------------------
Earnings per share - Diluted10.129.367.728.897.938.167.587.496.726.32
Weighted average common shares outstanding - Basic579.00577.60577.00588.50597.50604.70625.60649.20681.90693.90
Weighted average common shares outstanding - Diluted585.30582.20585.10602.00612.70618.70637.20662.00693.60703.30